{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-013992","form_type":"8-K","ticker":"LTRN","cik":"0001763950","company_name":"Lantern Pharma Inc.","filed_at":"2022-03-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.119955+00:00","generated_at":"2026-06-26T21:04:53.575482+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Lantern Pharma extends share repurchase program to July 31, 2022; $3.6M remaining authorization.","bullets":["Board extended existing share repurchase program through July 31, 2022, with $7M total authorization.","Since Nov 2021, 475,157 shares repurchased for ~$3.4M; $3.6M remaining as of March 21, 2022.","Company had $70.7M cash, equivalents, and marketable securities as of Dec 31, 2021.","Repurchases may occur on open market or privately; program may be suspended at any time."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-013992","json":"https://secwatch.observer/filing/0001213900-22-013992.json","markdown":"https://secwatch.observer/filing/0001213900-22-013992.md","text":"https://secwatch.observer/filing/0001213900-22-013992.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1763950/000121390022013992/0001213900-22-013992-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1763950/000121390022013992/ea157208-8k_lantern.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T21:04:53.575482+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}